VERA - Vera Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VERA is currently covered by 8 analysts with an average price target of $83.21. This is a potential upside of $33.78 (177.46%) from yesterday's end of day stock price of $29.99.

Vera Therapeutics's activity chart (see below) currently has 61 price targets and 69 ratings on display. The stock rating distribution of VERA is 81.25% BUY and 18.75% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40.93% with an average time for these price targets to be met of 116.25 days.

Highest price target for VERA is $110, Lowest price target is $34, average price target is $83.21.

Most recent stock forecast was given by ARTHUR HE from HC WAINWRIGHT on 11-Aug-2026. First documented stock forecast 07-Jun-2021.

Best performing analysts who are covering VERA - Vera Therapeutics:

Anupam Rama Liisa Bayko Steven Seedhouse Ed Arce Justin Kim Laura Chico

Currently out of the existing stock ratings of VERA, 13 are a BUY (81.25%), 3 are a HOLD (18.75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 04-May-2025

$90

$60.01 (200.10%)

$125

Hold Since 07-Nov-2024

$34

$4.01 (13.37%)

$43

Buy Since 15-Aug-2023

$76

$46.01 (153.42%)

$61

Buy Since 06-Oct-2024

$78

$48.01 (160.09%)

$73

Buy Since 15-Oct-2025

$70

$40.01 (133.41%)

$66

Show more analysts

Please expand the browser size to see the chart

What is VERA (Vera Therapeutics) average time for price targets to be met?

On average it took 116.25 days on average for the stock forecasts to be realized with a an average price target met ratio 40.93

Which analyst has the current highest performing score on VERA (Vera Therapeutics) with a proven track record?

ANUPAM RAMA

Which analyst has the most public recommendations on VERA (Vera Therapeutics)?

Anupam Rama works at JPMORGAN and has 34 price targets and 17 ratings on VERA

Which analyst is the currently most bullish on VERA (Vera Therapeutics)?

Pete Stavropoulos with highest potential upside - $70.01

Which analyst is the currently most reserved on VERA (Vera Therapeutics)?

Maury Raycroft with lowest potential downside - -$39.04

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?